by Elena Iemma | May 16, 2023 | Featured, News
EpiVax is celebrating 25 years of innovative immunoinformatics tool development. The company’s mission is to improve the safety and efficacy of vaccines and protein therapeutics, while working to improve human health everywhere. 1998 EpiVax Founded by Dr. Annie De...
by Annie De Groot | May 12, 2020 | Thinking Out Loud -Blog
Pepcid: From Poor Man’s Cure to $20M COVID-19 Trial Remember Hydrocychloroquine? The drug that doesn’t work for COVID-19? Well, here’s some good news for you. A crazy rock climber/mountain rescue nut named Michael Callahan and a brilliant group of...
by Annie De Groot | Jan 13, 2020 | Events
On Thursday 16 and Friday 17 January 2020, Dr. Annie De Groot will be in attendance of the Vaccinology Club of the French Society for Immunology at the Institut Pasteur in Lille, France. There she will be speaking in Session 1 on Thursday 16 January at 10:15AM on...
by Annie De Groot | Sep 17, 2017 | Featured, News
$5.8 MILLION AWARDED FOR VACCINE ENGINEERING WILL USE “IMMUNE HISTORY” TO PROTECT AGAINST BIRD FLU, A COLLABORATION LED BY EPIVAX PROVIDENCE, R.I., Sept. 18, 2017– EpiVax, Inc. (“EpiVax”) a pioneer in the fields of bioinformatics and immune engineering, today...
by Annie De Groot | May 24, 2017 | Featured, News, Thinking Out Loud -Blog
A new article in Nature Scientific Reports (doi: 10.1038/s41598-017-01372-5) entitled A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines may explain why H7N9 influenza vaccines are consistently less immunogenic in humans...
